Posted on April - 23 - 2010
AMS shares climb after new technology approved for US
Shares in Cheshire-based woundcare specialist Advanced Medical Solutions climbed more than four per cent after the firm said it had received approval from the US Food and Drug Administration for a new product which provides an alternative to staples and sutures in closing surgical incisions.
The AIM-listed firm’s shares gained 4.35 per cent, or 1.75p to 42p after the announcement.
Its product is part of the company’s LiquiBank range and allows initial wound closure followed by the application of an adhesive film to help prevent infection.
AMS chief executive Don Evans said FDA approval would increase the firm’s ability to penetrate the £130m US market.
Similar Posts:
- Tonic for investors as AMS plans dividends
- BFI zooms in for GB Group deal
- Cyprotex set for profits rise
- Optimism at Character Group sees shares soar
- Bglobal shares climb on back of Orange deal
